Correlation of sulfur mustard exposure and tobacco use with expression (immunoreactivity) of p53 protein in bronchial epithelium of Iranian "mustard lung" patients

Military Medicine

Volumn 172, Issue 1, 2007, Pages 70-74

  Ghanei, Mostafa ^a   Amiri, Somayyeh ^a   Akbari, Hassan ^a   Kosari, Farid ^a   Khalili, Ali Reza Hosseini ^a   Alaeddini, Farshid ^a   Aslani, Jafar ^a   Giardina, Charles ^b   Haines, David D ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUSTARD GAS; PROTEIN P53;

ARTICLE; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IRAN; LUNG BIOPSY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MUSTARD LUNG; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RISK FACTOR; SMOKING;

EID: 33846137295     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.172.1.70     Document Type: Article

References (20)

1. United Nations Security Council: Report of Specialists Appointed by the Secretary General to Investigate Allegations by the Islamic Republic of Iran Concerning the Use of Chemical Weapons. Publication S/16433/1986. New York, NY, United Nations Security Council, 1986.
2. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D: Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 2003; 45: 1136-43.
3. Safarinejad MR, Moosavi SA, Montazeri B: Ocular injuries caused by mustard gas: diagnosis, treatment, and medical defense. Milit Med 2001; 166: 67-70.
4. Balali M: Clinical and laboratory findings in Iranian fighters with chemical gas poisoning. Arch Belg 1984; Suppl: 254-9.
5. Momeni AZ, Aminjavaheri M: Skin manifestations of mustard gas in a group of 14 children and teenagers: a clinical study. Int J Dermatol 1994; 33: 184-7.
6. Emad A, Rezaian GR: The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest 1997; 112: 734-8.
7. Emad A, Rezaian GR: Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest 1999; 115: 1346-51.
8. Takeshima Y, Inai K, Bennett WP, et al: p53 mutations in lung cancers from Japanese mustard gas workers. Carcinogenesis 1994; 15: 2075-9.
9. Amundson SA, Myers TG, Fornace AJ Jr: Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 1998; 17: 3287-99.
10. Boers JE, ten Velde GP, Thunnissen FB: p53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma. Am J Respir Crit Care Med 1996; 153: 411-6.
11. Neri M, Ugolini D, Bonassi S, et al: Children's exposure to environmental pollutants and biomarkers, of genetic damage, part II: results of a comprehensive literature search and meta-analysis. Mutat Res 2006; 612: 14-39.
12. Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Shields PG, Harris CC: Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. J Pathol 1999; 187: 8-18.
13. American Thoracic Society: Standardization of spirometry: 1987 update. Am Rev Respir Dis 1987; 136: 1285-98.
14. Soini Y, Paakko P, Nuorva K, Kamel D, Lane DP, Vahakangas K: Comparative analysis of p53 protein immunoreactivity in prostatic. lung and breast carcinomas. Virchows Arch A Pathol Anat Histopathol 1992; 421: 223-8.
15. Oren M, Prives C: p53: upstream, downstream and off stream: review of the 8th p53 Workshop (Dundee, July 5-9, 1996). Biochim Biophys Acta 1996; 1288: R13-9.
16. Picksley SM, Lane DP: The p53-mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53? BioEssays 1993; 15: 689-90.
17. Alarcon-Vargas D, Ronai Z: p53-Mdm2: the affair that never ends. Carcinogenesis 2002; 23: 541-7.
18. Hanai T, Yatabe Y, Nakayama Y, et al: Prognostic models in patients with non-small-cell lung cancer using artificial neural networks in comparison with logistic regression. Cancer Sci 2003; 94: 473-7.
19. Mitsuuchi Y, Testa JR: Cytogenetics and molecular genetics of lung cancer. Am J Med Genet 2002; 115: 183-8.
20. Olivier M, Hussain SP, Caron de Fromentel C, Hainaut P, Harris CC: TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci Publ 2004; 157: 247-70.